BPG is committed to discovery and dissemination of knowledge
Featured Articles
7/24/2025 8:45:24 AM | Browse: 18 | Download: 23
 |
Received |
|
2025-05-12 12:55 |
|
Peer-Review Started |
|
2025-05-12 12:56 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-05-26 20:39 |
|
Revised |
|
2025-05-30 17:39 |
|
Second Decision |
|
2025-07-03 02:41 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-07-03 06:15 |
|
Articles in Press |
|
2025-07-03 06:15 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-07-09 09:11 |
|
Publish the Manuscript Online |
|
2025-07-24 07:47 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Editorial |
| Article Title |
Duodenal mucosal ablation: An emerging therapeutic concept for metabolic dysfunction-associated fatty liver disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Cornelius J Fernandez, Sweekruti Jena, Vijaya Lakshmi and Joseph M Pappachan |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Joseph M Pappachan, Academic Editor, FRCP, MD, MRCP, Professor, Senior Researcher, Faculty of Science, Manchester Metropolitan University, All Saints Building, Oxford Road, Manchester M15 6BH, United Kingdom. drpappachan@yahoo.co.in |
| Key Words |
Duodenal mucosal ablation; Endoscopic bariatric procedure; Type 2 diabetes mellitus; Metabolic and bariatric surgery; Obesity; Hepatic steatosis; Metabolic dysfunction-associated fatty liver disease |
| Core Tip |
Metabolic dysfunction-associated fatty liver disease is recognized as the most common cause of chronic liver disease globally with obesity being the prime driver for insulin resistance and hepatic steatosis. Though metabolic and bariatric surgery (MBS) is the most effective treatment option for severe obesity, it carries complication risks and long-term commitment to lifestyle adjustments. In the evolving landscape of obesity management, minimally invasive endoscopic bariatric therapies offer promising weight loss and metabolic benefits with lower complication rates compared to MBS. This editorial provides a comprehensive overview of various endoscopic bariatric techniques used in management of obesity and their effect on metabolic dysfunction-associated fatty liver disease which will help physicians to offer safer alternatives to conventional MBS. |
| Publish Date |
2025-07-24 07:47 |
| Citation |
<p>Fernandez CJ, Jena S, Lakshmi V, Pappachan JM. Duodenal mucosal ablation: An emerging therapeutic concept for metabolic dysfunction-associated fatty liver disease. <i>World J Gastroenterol</i> 2025; 31(28): 109468</p> |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i28/109468.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i28.109468 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
